2m 2m 2m 2m 2m 2m 2m
OUTSET MEDICAL (OM)
NASDAQ
$4.73+$0.13 (+2.72%)
Price as of Jun 03, 2026 4:24 PM EDT- $90.6MMarket Cap
- -76.19%1-Year Change
- Medical DevicesIndustry
OUTSET MEDICAL (OM)
$4.73+$0.13 (+2.72%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 84.8M -25.40% | 113.7M -12.80% | 130.4M +13.00% | 115.4M +12.45% | |
Cost of Revenue | 43.8M -41.74% | 75.1M -25.89% | 101.4M +3.93% | 97.5M +2.68% | |
Gross Profit | 46.8M +21.24% | 38.6M +32.98% | 29.0M +62.62% | 17.8M +134.40% | |
Sales and Marketing Expense | 54.4M -22.39% | 70.0M -27.21% | 96.2M +7.54% | 89.5M +37.52% | |
Research and Development Expense | -21.2M -44.70% | -38.4M -33.00% | -57.3M +17.30% | -48.9M +32.97% | |
Depreciation and Amortization Expense | 4.3M -24.21% | 5.7M -1.41% | 5.8M +12.40% | 5.2M +0.14% | |
Total Operating Expenses | 113.5M -25.33% | 151.9M -23.56% | 198.8M +11.14% | 178.9M +29.48% | |
Operating Profit | -66.7M -41.16% | -113.4M -33.22% | -169.8M +5.43% | -161.0M +23.37% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -14.0M -41.55% | -23.9M +88.33% | -12.7M +255.44% | -3.6M +107.93% | |
Interest Income and Expense and Net | -14.0M -41.55% | -23.9M +88.33% | -12.7M +255.44% | -3.6M +107.93% | |
Total Nonoperating Income and Expense | 7.4M -24.11% | 9.8M -4.03% | 10.2M +209.05% | 3.3M +560.84% | |
Income before Taxes | -80.9M -36.51% | -127.5M -26.00% | -172.3M +5.91% | -162.7M +23.47% | |
Income Taxes | 718,000 +46.23% | 491,000 -6.12% | 523,000 +77.29% | 295,000 +48.24% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -81.7M -36.20% | -128.0M -25.94% | -172.8M +6.04% | -163.0M +23.51% | |
Net Income from Continuing Operations Applicable to Common | -80.9M -36.51% | -127.5M -26.00% | -172.3M +5.91% | -162.7M +23.47% | |
Basic EPS and Net Income | -5.37 +118.29% | -2.46 -29.31% | -3.48 +2.96% | -3.38 +16.96% | |
Diluted EPS and Net Income | -5.37 +118.29% | -2.46 -29.31% | -3.48 +2.96% | -3.38 +16.96% | |
Basic Weighted Average Shares | 15,211 -70.72% | 51,951 +4.77% | 49,588 +2.96% | 48,161 -99.89% | |
Diluted Weighted Average Shares | 15,211 -70.72% | 51,951 +4.77% | 49,588 +2.96% | 48,161 -99.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 35.0M -71.77% | 124.0M +81.02% | 68.5M -6.44% | 73.2M -59.84% | |
Short-Term Investments | 133.9M +286.32% | 34.7M -74.28% | 134.8M -37.08% | 214.3M +36.36% | |
Cash and Cash Equivalents and Short-Term Investments | 168.9M +6.47% | 158.7M -21.95% | 203.3M -29.28% | 287.5M -15.31% | |
Total Current Assets | 250.9M -2.84% | 258.2M -11.33% | 291.2M -22.06% | 373.6M -8.82% | |
Accumulated Depreciation | 24.9M +18.43% | 21.0M +28.42% | 16.4M +51.49% | 10.8M +41.19% | |
Property and Plant and Equipment and Net | 4.7M -42.58% | 8.1M -38.73% | 13.3M -16.40% | 15.9M +22.46% | |
Total Long-Term Assets | 317,000 -85.41% | 2.2M +259.01% | 605,000 -48.11% | 1.2M +647.44% | |
Total Assets | 264.5M -4.10% | 275.8M -12.11% | 313.8M -21.57% | 400.1M -13.67% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 4.8M +134.57% | |
Total Current Liabilities | 37.6M -17.07% | 45.4M -17.98% | 55.3M +6.49% | 51.9M +0.49% | |
Total Long-Term Debt | 96.2M -51.24% | 197.4M +51.70% | 130.1M +35.06% | 96.3M +223.69% | |
Total Long-Term Liabilities | 99.9M -50.27% | 200.9M +49.15% | 134.7M +31.97% | 102.1M +176.09% | |
Total Liabilities | 137.5M -44.76% | 249.0M +30.41% | 190.9M +23.87% | 154.1M +72.43% | |
Retained Earnings | -1.2B +7.49% | -1.1B +13.31% | -961.7M +21.90% | -789.0M +26.03% | |
Total Stockholders Equity | 127.0M +373.37% | 26.8M -78.18% | 122.9M -50.04% | 246.0M -34.24% | |
Total Shares Outstanding | 18.2M -65.68% | 52.9M +5.22% | 50.3M +3.82% | 48.5M +2.59% | |
Cash Flow | |||||
Cash from Operating Activities | -46.3M -60.17% | -116.3M -11.47% | -131.4M -9.85% | -145.7M +11.87% | |
Capital Expenditures | 798,000 -12.50% | 912,000 -73.49% | 3.4M -58.68% | 8.3M +167.86% | |
Cash from Investing Activities | -97.7M -193.98% | 103.9M +25.19% | 83.0M +225.24% | -66.3M -53.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 55.5M -18.22% | 67.9M +55.48% | 43.7M -40.12% | 72.9M -54.48% | |
Financials Ratio | |||||
Gross Margin | 48.40% +42.67% | 33.92% +52.50% | 22.24% +43.91% | 15.46% +108.45% | |
Operating Margin | -78.66% -21.13% | -99.72% -23.42% | -130.22% -6.70% | -139.56% +9.71% | |
Return on Assets | -30.23% -30.37% | -43.41% -10.32% | -48.41% +28.27% | -37.74% +24.04% | |
Return on Equity | -106.20% -37.88% | -170.97% +82.49% | -93.69% +78.25% | -52.56% +39.97% | |
Revenue Growth | -25.40% +98.48% | -12.80% -198.44% | 13.00% +4.44% | 12.45% -88.20% | |
Current Ratio | 6.67 +17.16% | 5.69 +8.10% | 5.26 -26.81% | 7.19 -9.27% | |
Cash Ratio | 0.93 -65.96% | 2.73 +120.70% | 1.24 -12.15% | 1.41 -60.04% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.41 +383.41% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.25 +268.22% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow